Seeing Is Believing

Currently out of the existing stock ratings of Evan Wilson, 9 are a BUY (69.23%), 4 are a HOLD (30.77%).
Analyst Evan Wilson, carries an average stock price target met ratio of 89.68% that have a potential upside of 22.56% achieved within 484 days. Previously, Evan Wilson worked at KEYBANK.
Evan Wilson’s has documented 65 price targets and ratings displayed on 8 stocks. The coverage was on Communication Services, Healthcare, Technology, Consumer Cyclical sectors.
Most recent stock forecast was given on RPD, Rapid7 at 07-Nov-2023.
Analyst best performing recommendations are on CRL (CHARLES RIVER LABORATORIES).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES) at 4/11/2019. The price target of $135 was fulfilled within 6 days with a profit of $9.21 (6.39%) receiving and performance score of 10.64.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Jan-2023
$95
$0.58 (0.61%)
$95.99
2 years 4 months 24 days ago
(22-Sep-2023)
0/4 (0%)
$1.08 (1.15%)
Hold Since 21-Jul-2023
$95
$0.58 (0.61%)
$95
2 years 6 months 25 days ago
(21-Jul-2023)
15/20 (75%)
$4.07 (4.48%)
214
Buy Since 16-Feb-2023
$96
$1.58 (1.67%)
$95
2 years 6 months 26 days ago
(20-Jul-2023)
2/6 (33.33%)
$4.69 (5.14%)
137
Hold Since 20-Jul-2023
$90
$-4.42 (-4.68%)
$90
2 years 6 months 26 days ago
(20-Jul-2023)
7/11 (63.64%)
$-1.31 (-1.43%)
83
Hold Since 20-Jul-2023
$95
$0.58 (0.61%)
$95
2 years 6 months 26 days ago
(20-Jul-2023)
13/20 (65%)
$3.69 (4.04%)
310
What Year was the first public recommendation made by Evan Wilson?